Clinical Trial Update: IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity [Phase 2]

View source ↗

Summary

Phase 2 trial investigating IGF-1/IGFBP3 for prevention of retinopathy of prematurity has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinopathy of Prematurity

Drugs mentioned

• IGF-1/IGFBP3

Snippet

Sponsor: Shire | Conditions: Retinopathy of Prematurity (ROP) | Phase 2 | Status: COMPLETED | Results posted: 2017-06-07